Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.86 | N/A |
| PEG Ratio (TTM) | 2.26 | N/A |
| P/S Ratio (TTM) | 1.30 | N/A |
| P/B Ratio (TTM) | 1.96 | N/A |
| P/FCF Ratio (TTM) | 17.51 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.89 | N/A |
| Price to 5YR AVG FCF Ratio | 17.72 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 16.99% | N/A |
| ROE (TTM) | 26.23% | N/A |
| Net Profit Margin (TTM) | 16.64% | N/A |
| ROIC 5YR AVG | 28.45% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.69% | 28.91% | 28.40% |
| Revenue | 3.25% | 11.50% | 10.00% |
| Net Income | 3.21% | 25.40% | 22.02% |
| Cash Flow | 7.37% | -1.27% | 38.28% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.29 | N/A |
| Quick Ratio (TTM) | 0.44 | N/A |
| D/E Ratio (TTM) | 0.14 | N/A |
| Interest Coverage (TTM) | 10,441.78 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 5.69 | N/A |
| LTL to 5YR AVG FCF | 1.60 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.92% | N/A |